Several groups of epigenetic drugs, such as Enhancer of zeste homolog 2 (EZH2) inhibitors, HDAC inhibitors, and DNA methylation inhibitors, are playing an increasingly important role in the management of cancer. Here, EZH2 is linked to cancer.